FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding repeated







FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding repeated










FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding…

Generic manufacturers may shift focus to reliability due to supply chain issues and price pressure affecting the industry.

Fresenius expands biosimilars portfolio through big deal with WuXi Biologics, gaining option rights on up to 37 candidates.

Germany's AfD softens anti euro stance ahead of national government hopes. Explore the party's strategic shift and political…

Trump veto looms as Democrats win Congress, sparking fresh trade hurdles, oversight hearings and plans to roll back…

France deploys 70,000 police to contain nationwide protests over living costs and government policies, following recent riots and…

Diplomats face deep rifts over wars and trade at the G20 meeting in Atlanta, with Secretary of State…

Patients struggle to find accepting doctors nationwide, facing repeated rejections despite Medicare coverage and family recommendations.

FBI Special Agent Bryan Witt raises concerns about political motives in the case against former counterintelligence officials Nikki…

Russia accused of war crimes in Ukraine, deliberately striking power grid and conscripting fighters from 29 nations.